Atlas Capital Advisors’s GMO US Quality ETF QLTY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$13.7K Sell
400
-200
-33% -$6.34K ﹤0.01% 748
2025
Q1
$18.8K Sell
600
-400
-40% -$13.1K ﹤0.01% 743
2024
Q4
$32K Hold
1,000
﹤0.01% 670
2024
Q3
$32.6K Buy
+1,000
New +$31.4K 0.01% 631

Other funds holding QLTY

Atlas Capital Advisors's QLTY Position: Q2 2025 in Review

Atlas Capital Advisors reduced its GMO US Quality ETF (QLTY) stake by 33% in Q2 2025, selling an estimated $6.34K and leaving 400 shares worth $13.7K. The position accounts for ﹤0.01% of the portfolio, ranked #748.

Atlas Capital Advisors first reported a position in QLTY in Q3 2024 and has held it in 4 quarters since. The position peaked at $32.6K in Q3 2024. 111 funds tracked by Wall St. Rank hold QLTY as of Q2 2025.

  • Atlas Capital Advisors held 400 shares of GMO US Quality ETF worth $13.7K as of Q2 2025.
  • Atlas Capital Advisors sold 200 GMO US Quality ETF shares in Q2 2025, an estimated $6.34K.
  • GMO US Quality ETF made up ﹤0.01% of Atlas Capital Advisors's portfolio in Q2 2025, its #748 holding.
  • Atlas Capital Advisors first reported a position in GMO US Quality ETF in Q3 2024 and has held it in 4 quarters since.
  • Atlas Capital Advisors's GMO US Quality ETF position peaked at $32.6K in Q3 2024.
  • 111 funds tracked by Wall St. Rank held GMO US Quality ETF as of Q2 2025.

Based on Atlas Capital Advisors's 13F filing for Q2 2025, filed 12 Aug 2025.